Your browser doesn't support javascript.
loading
Predicting sulforaphane-induced adverse effects in colon cancer patients via in silico investigation.
Bozic, Dragica; Baralic, Katarina; Zivancevic, Katarina; Miljakovic, Evica Antonijevic; Curcic, Marijana; Antonijevic, Biljana; Djordjevic, Aleksandra Buha; Bulat, Zorica; Zhang, Yi; Yang, Li; Dukic-Cosic, Danijela.
Afiliación
  • Bozic D; Department of Toxicology "Akademik Danilo Soldatovic", University of Belgrade - Faculty of Pharmacy, Vojvode Stepe 450, 11221 Belgrade, Serbia; Biotherapy Center, The First Affiliated Hospital of Zhengzhou University, No.1 Jianshe Road, Zhengzhou 450052, Henan, China. Electronic address: djorgovanov
  • Baralic K; Department of Toxicology "Akademik Danilo Soldatovic", University of Belgrade - Faculty of Pharmacy, Vojvode Stepe 450, 11221 Belgrade, Serbia.
  • Zivancevic K; Department of Toxicology "Akademik Danilo Soldatovic", University of Belgrade - Faculty of Pharmacy, Vojvode Stepe 450, 11221 Belgrade, Serbia.
  • Miljakovic EA; Department of Toxicology "Akademik Danilo Soldatovic", University of Belgrade - Faculty of Pharmacy, Vojvode Stepe 450, 11221 Belgrade, Serbia; Center for Toxicological Risk Assessment, University of Belgrade - Faculty of Pharmacy, Vojvode Stepe 450, 11221 Belgrade, Serbia.
  • Curcic M; Department of Toxicology "Akademik Danilo Soldatovic", University of Belgrade - Faculty of Pharmacy, Vojvode Stepe 450, 11221 Belgrade, Serbia; Center for Toxicological Risk Assessment, University of Belgrade - Faculty of Pharmacy, Vojvode Stepe 450, 11221 Belgrade, Serbia.
  • Antonijevic B; Department of Toxicology "Akademik Danilo Soldatovic", University of Belgrade - Faculty of Pharmacy, Vojvode Stepe 450, 11221 Belgrade, Serbia; Center for Toxicological Risk Assessment, University of Belgrade - Faculty of Pharmacy, Vojvode Stepe 450, 11221 Belgrade, Serbia.
  • Djordjevic AB; Department of Toxicology "Akademik Danilo Soldatovic", University of Belgrade - Faculty of Pharmacy, Vojvode Stepe 450, 11221 Belgrade, Serbia; Center for Toxicological Risk Assessment, University of Belgrade - Faculty of Pharmacy, Vojvode Stepe 450, 11221 Belgrade, Serbia.
  • Bulat Z; Department of Toxicology "Akademik Danilo Soldatovic", University of Belgrade - Faculty of Pharmacy, Vojvode Stepe 450, 11221 Belgrade, Serbia; Center for Toxicological Risk Assessment, University of Belgrade - Faculty of Pharmacy, Vojvode Stepe 450, 11221 Belgrade, Serbia.
  • Zhang Y; Biotherapy Center, The First Affiliated Hospital of Zhengzhou University, No.1 Jianshe Road, Zhengzhou 450052, Henan, China.
  • Yang L; Biotherapy Center, The First Affiliated Hospital of Zhengzhou University, No.1 Jianshe Road, Zhengzhou 450052, Henan, China.
  • Dukic-Cosic D; Department of Toxicology "Akademik Danilo Soldatovic", University of Belgrade - Faculty of Pharmacy, Vojvode Stepe 450, 11221 Belgrade, Serbia; Center for Toxicological Risk Assessment, University of Belgrade - Faculty of Pharmacy, Vojvode Stepe 450, 11221 Belgrade, Serbia.
Biomed Pharmacother ; 146: 112598, 2022 Feb.
Article en En | MEDLINE | ID: mdl-34959120
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Sulfóxidos / Isotiocianatos / Neoplasias del Colon Tipo de estudio: Prognostic_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: Biomed Pharmacother Año: 2022 Tipo del documento: Article
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Sulfóxidos / Isotiocianatos / Neoplasias del Colon Tipo de estudio: Prognostic_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: Biomed Pharmacother Año: 2022 Tipo del documento: Article